Full-text

Journal article

Negative phase 3 randomized controlled trials: Why cancer drugs fail the last barrier?

Gyawali B Civil Service Hospital, Kathmandu, Nepal.
Addeo A Oncology Department, University Hospital Geneva, Rue Gabrielle-Perret-Gentil 4, Geneva, Switzerland.

2018-05-11

Published in:

International journal of cancer. - 2018

Antineoplastic Agents

Clinical Trials, Phase III as Topic

Humans

Neoplasms

Randomized Controlled Trials as Topic

Language

English

Open access status

bronze

Identifiers

DOI 10.1002/ijc.31583
PMID 29744864

Persistent URL

https://sonar.ch/global/documents/232712

Statistics

Document views: 18 File downloads:

Full-text: 0